Hjem › Glioblastom › District of Columbia
Kliniske studier for Glioblastom i District of Columbia
9 studier for Glioblastom søker deltakere på steder i District of Columbia.
Byer i District of Columbia
Offisiell studietekst (engelsk)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07326566Targeted Pediatric High-Grade Glioma Therapy
- Children's National Medical Center, Washington D.C.
RekruttererObservasjonsstudie
12 Months – 39 Years · Alle kjønn · Oppdatert 8. sep. 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Children's National Medical Center, Washington D.C.
RekruttererFase 2
Alder 12 til 39 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06161974Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Children's National Medical Center, Washington D.C.
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
Alder 1 til 21 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT06333899A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
- Children's National Hospital, Washington D.C.
RekruttererFase 1
Alder 4 og eldre · Alle kjønn · Oppdatert 25. jun. 2026 · NCT04573140ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- Children's National Hospital, Washington D.C.
RekruttererFase 1
Alder 2 til 21 · Alle kjønn · Oppdatert 11. jun. 2026 · NCT04732065Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Children's National Medical Center, Washington D.C.
RekruttererFase 2
12 Months – 39 Years · Alle kjønn · Oppdatert 29. mai 2026 · NCT05843253Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Sibley Memorial Hospital, Washington D.C.
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. apr. 2026 · NCT06810544Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
- Sibley Memorial Hospital, Washington D.C.
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. nov. 2024 · NCT05768919Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.